Jelle van Schooten
Overview
Explore the profile of Jelle van Schooten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Corrigan A, Duan H, Cheng C, Gonelli C, Ou L, Xu K, et al.
Cell Rep
. 2021 Apr;
35(1):108937.
PMID: 33826898
Soluble "SOSIP"-stabilized envelope (Env) trimers are promising HIV-vaccine immunogens. However, they induce high-titer responses against the glycan-free trimer base, which is occluded on native virions. To delineate the effect on...
12.
Brouwer P, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Grobben M, Claireaux M, et al.
Cell
. 2021 Feb;
184(5):1188-1200.e19.
PMID: 33577765
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that...
13.
Liu H, Wu N, Yuan M, Bangaru S, Torres J, Caniels T, et al.
Immunity
. 2020 Nov;
53(6):1272-1280.e5.
PMID: 33242394
Most antibodies isolated from individuals with coronavirus disease 2019 (COVID-19) are specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, COVA1-16 is a relatively rare antibody that also cross-neutralizes...
14.
Cottrell C, van Schooten J, Bowman C, Yuan M, Oyen D, Shin M, et al.
PLoS Pathog
. 2020 Sep;
16(8):e1008753.
PMID: 32866207
The induction of broad and potent immunity by vaccines is the key focus of research efforts aimed at protecting against HIV-1 infection. Soluble native-like HIV-1 envelope glycoproteins have shown promise...
15.
Liu H, Wu N, Yuan M, Bangaru S, Torres J, Caniels T, et al.
bioRxiv
. 2020 Aug;
PMID: 32793906
Most antibodies isolated from COVID-19 patients are specific to SARS-CoV-2. COVA1-16 is a relatively rare antibody that also cross-neutralizes SARS-CoV. Here we determined a crystal structure of COVA1-16 Fab with...
16.
Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al.
Science
. 2020 Jun;
369(6504):643-650.
PMID: 32540902
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a large impact on global health, travel, and economy. Therefore, preventative and therapeutic measures are urgently needed....
17.
van Schooten J, van Gils M
Retrovirology
. 2018 Nov;
15(1):74.
PMID: 30477581
Despite enormous efforts no HIV-1 vaccine has been developed that elicits broadly neutralizing antibodies (bNAbs) to protect against infection to date. The high antigenic diversity and dense N-linked glycan armor,...